HomeCYCN • NASDAQ
add
Cyclerion Therapeutics Inc
Previous close
$6.38
Day range
$4.65 - $6.75
Year range
$1.03 - $8.48
Market cap
24.14M USD
Avg Volume
8.86M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.02M | -43.24% |
Operating expense | 2.30M | 50.13% |
Net income | -799.00K | -250.75% |
Net profit margin | -77.95 | -365.59% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.24M | 0.25% |
Total assets | 9.98M | 4.28% |
Total liabilities | 900.00K | 24.14% |
Total equity | 9.08M | — |
Shares outstanding | 4.33M | — |
Price to book | 2.68 | — |
Return on assets | -20.54% | — |
Return on capital | -22.50% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -799.00K | -250.75% |
Cash from operations | -1.58M | -538.61% |
Cash from investing | — | — |
Cash from financing | 251.00K | — |
Net change in cash | -1.33M | -468.89% |
Free cash flow | -1.74M | -1,313.74% |
About
Founded
2018
Website
Employees
1
